Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Carcinoembryonic antigen.

R H Fletcher

    Annals of Internal Medicine
    |January 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Carcinoembryonic antigen (CEA) levels can indicate cancer but are not reliable for early detection or diagnosis. While CEA monitoring aids in detecting colorectal cancer recurrence, it offers limited impact on patient survival rates.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Conflict of interest in peer-reviewed medical journals: the World Association of Medical Editors (WAME) position on a challenging problem.

    The international journal of occupational and environmental medicine·2012
    Same author

    Conflict of interest in peer-reviewed medical journals: the world association of medical editors position on a challenging problem.

    Journal of young pharmacists : JYP·2011
    Same author

    Conflict of interest in peer-reviewed medical journals: The world association of medical editors position on a challenging problem.

    Pharmacognosy magazine·2010
    Same author

    Research evidence and the individual patient.

    QJM : monthly journal of the Association of Physicians·2003
    Same author

    Alvan Feinstein, the father of clinical epidemiology, 1925-2001.

    Journal of clinical epidemiology·2002
    Same author

    Measuring access to effective care among elderly medicare enrollees in managed and Fee-for-Service care: a retrospective cohort study.

    BMC health services research·2001
    Same journal

    Correction to I.M. Matters News: Sleep medicine for seniors.

    Annals of internal medicine·2026
    Same journal

    Adverse Events After Same-Day COVID-19 and Influenza Vaccination Versus Influenza Vaccination Alone : A Target Trial Emulation.

    Annals of internal medicine·2026
    Same journal

    Leveraging Real-World Evidence to Inform Regulatory, Clinical, and Coverage Decisions Related to Glucagon-Like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

    Annals of internal medicine·2026
    Same journal

    Methodological Approaches to Real-World Evidence Generation for Glucagon-like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

    Annals of internal medicine·2026
    Same journal

    Weekly and Biweekly Treatment With Bofanglutide Versus Semaglutide in Chinese Patients With Type 2 Diabetes : A Phase 2b Randomized Clinical Trial.

    Annals of internal medicine·2026
    Same journal

    Grappling with GLP-1 prescribing.

    Annals of internal medicine·2026
    See all related articles

    Area of Science:

    • Oncology
    • Clinical Chemistry

    Background:

    • Elevated serum carcinoembryonic antigen (CEA) is observed in cancer patients.
    • The clinical utility of CEA as a biomarker is under review.

    Purpose of the Study:

    • To evaluate the clinical usefulness of serum carcinoembryonic antigen (CEA) levels in cancer management.
    • To assess the diagnostic and prognostic value of CEA in various cancer types.

    Main Methods:

    • Review of existing literature on carcinoembryonic antigen (CEA) assays in oncology.
    • Analysis of CEA's sensitivity, specificity, and prognostic capabilities.

    Main Results:

    • CEA is not effective for detecting asymptomatic cancer due to low sensitivity and specificity, leading to false results.

    Related Experiment Videos

  • CEA levels alone lack sufficient diagnostic certainty for confirming or excluding cancer.
  • While CEA offers prognostic insights for some cancers, it does not improve treatment efficacy.
  • Post-surgery CEA monitoring in colorectal cancer detects recurrence early, but with minimal impact on survival.

    • Conclusions:

    • Carcinoembryonic antigen (CEA) assays provide accurate data on certain cancer aspects.
    • CEA's application in improving patient outcomes remains limited.